Fecal Occult Blood and Fecal Calprotectin as Point-of-Care Markers of Intestinal Morbidity in Ugandan Children with Schistosoma mansoni Infection

PLoS Neglected Tropical Diseases

Volumn 7, Issue 11, 2013, Pages

  Bustinduy, Amaya L ^a   Sousa Figueiredo, José C ^a,b   Adriko, Moses ^c   Betson, Martha ^d   Fenwick, Alan ^e   Kabatereine, Narcis ^c   Stothard, J Russell ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c MINISTRY OF HEALTH   (Uganda)

^d ROYAL VETERINARY COLLEGE   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; HEMOGLOBIN; PRAZIQUANTEL;

ANEMIA; ARTICLE; CHILD; DISEASE ASSOCIATION; EGG PARASITOID; ENTERITIS; FEMALE; FOLLOW UP; HUMAN; INTESTINE INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OCCULT BLOOD; PARASITE IDENTIFICATION; POINT OF CARE TESTING; PRESCHOOL CHILD; PREVALENCE; SCHISTOSOMIASIS MANSONI; SCHOOL CHILD; UGANDA; ANIMAL; BLOOD; FECES; INTESTINE; PARASITOLOGY; PATHOGENICITY; SCHISTOSOMA MANSONI;

ANIMALS; CHILD; CHILD, PRESCHOOL; FECES; FEMALE; HUMANS; INTESTINES; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; OCCULT BLOOD; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

EID: 84888255190     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002542     Document Type: Article

References (40)

1. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J, (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6: 411-425.
2. Garba A, Barkire N, Djibo A, Lamine MS, Sofo B, et al. (2010) Schistosomiasis in infants and preschool-aged children: Infection in a single Schistosoma haematobium and a mixed S. haematobium-S. mansoni foci of Niger. Acta Trop 115: 212-219.
3. Savioli L, Engels D, Roungou JB, Fenwick A, Endo H, (2004) Schistosomiasis control. Lancet 363: 658.
4. Webster JP, Koukounari A, Lamberton PH, Stothard JR, Fenwick A, (2009) Evaluation and application of potential schistosome-associated morbidity markers within large-scale mass chemotherapy programmes. Parasitology 136: 1789-1799.
5. Cao J, Liu WJ, Xu XY, Zou XP, (2010) Endoscopic findings and clinicopathologic characteristics of colonic schistosomiasis: a report of 46 cases. World J Gastroenterol 16: 723-727.
6. El-Shabrawi MH, El Din ZE, Isa M, Kamal N, Hassanin F, et al. (2011) Colorectal polyps: a frequently-missed cause of rectal bleeding in Egyptian children. Ann Trop Paediatr 31: 213-218.
7. Kanzaria HK, Acosta LP, Langdon GC, Manalo DL, Olveda RM, et al. (2005) Schistosoma japonicum and occult blood loss in endemic villages in Leyte, the Philippines. Am J Trop Med Hyg 72: 115-118.
8. Lehman JS Jr, Mott KE, Morrow RH Jr, Muniz TM, Boyer MH, (1976) The intensity and effects of infection with Schistosoma mansoni in a rural community in northeast Brazil. Am J Trop Med Hyg 25: 285-294.
9. Ndamba J, Makaza N, Kaondera KC, Munjoma M, (1991) Morbidity due to Schistosoma mansoni among sugar-cane cutters in Zimbabwe. Int J Epidemiol 20: 787-795.
10. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, et al. (2009) American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 104: 739-750.
11. Guittet L, Bouvier V, Mariotte N, Vallee JP, Levillain R, et al. (2009) Comparison of a guaiac and an immunochemical faecal occult blood test for the detection of colonic lesions according to lesion type and location. Br J Cancer 100: 1230-1235.
12. Okamoto M, Kawabe T, Ohata K, Togo G, Hada T, et al. (2005) Amebic colitis in asymptomatic subjects with positive fecal occult blood test results: clinical features different from symptomatic cases. Am J Trop Med Hyg 73: 934-935.
13. Stoltzfus RJ, Albonico M, Chwaya HM, Savioli L, Tielsch J, et al. (1996) Hemoquant determination of hookworm-related blood loss and its role in iron deficiency in African children. Am J Trop Med Hyg 55: 399-404.
14. Wanachiwanawin D, Wongkamchai S, Loymek S, Suvuttho S, Monkon N, et al. (2005) Determination of fecal occult blood in primary schoolchildren infected with Trichuris trichiura. Southeast Asian J Trop Med Public Health 36: 1110-1113.
15. Betson M, Sousa-Figueiredo JC, Kabatereine NB, Stothard JR, (2012) Use of fecal occult blood tests as epidemiologic indicators of morbidity associated with intestinal schistosomiasis during preventive chemotherapy in young children. Am J Trop Med Hyg 87: 694-700.
16. Betson M, Sousa-Figueiredo JC, Rowell C, Kabatereine NB, Stothard JR, (2010) Intestinal schistosomiasis in mothers and young children in Uganda: investigation of field-applicable markers of bowel morbidity. Am J Trop Med Hyg 83: 1048-1055.
17. Sousa-Figueiredo JC, Betson M, Atuhaire A, Arinaitwe M, Navaratnam AM, et al. (2012) Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children. PLoS Negl Trop Dis 6: e1864.
18. Foell D, Wittkowski H, Roth J, (2009) Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage. Gut 58: 859-868.
19. Komraus M, Wos H, Wiecek S, Kajor M, Grzybowska-Chlebowczyk U, (2012) Usefulness of faecal calprotectin measurement in children with various types of inflammatory bowel disease. Mediators Inflamm 2012: 608249.
20. Berni Canani R, Rapacciuolo L, Romano MT, Tanturri de Horatio L, Terrin G, et al. (2004) Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice. Dig Liver Dis 36: 467-470.
21. Sherwood RA, (2012) Faecal markers of gastrointestinal inflammation. J Clin Pathol 65: 981-985.
22. Chen CC, Huang JL, Chang CJ, Kong MS, (2012) Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children. J Pediatr Gastroenterol Nutr 55: 541-547.
23. Sousa-Figueiredo JC, Pleasant J, Day M, Betson M, Rollinson D, et al. (2010) Treatment of intestinal schistosomiasis in Ugandan preschool children: best diagnosis, treatment efficacy and side-effects, and an extended praziquantel dosing pole. Int Health 2: 103-113.
24. Katz N, Chaves A, Pellegrino J, (1972) A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 14: 397-400.
25. Crompton DWT, World Health Organization. (2006) Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. Geneva: World Health Organization. 62 p. p.
26. van Etten L, Folman CC, Eggelte TA, Kremsner PG, Deelder AM, (1994) Rapid diagnosis of schistosomiasis by antigen detection in urine with a reagent strip. J Clin Microbiol 32: 2404-2406.
27. WHO (2008) Worldwide prevalence of anaemia 1993-2005.
28. Diamanti A, Panetta F, Basso MS, Forgione A, Colistro F, et al. (2010) Diagnostic work-up of inflammatory bowel disease in children: the role of calprotectin assay. Inflamm Bowel Dis 16: 1926-1930.
29. Stothard JR, Sousa-Figueiredo JC, Betson M, Green HK, Seto EY, et al. (2011) Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children. Parasitology 138: 1593-1606.
30. Sousa-Figueiredo JC, Basanez MG, Mgeni AF, Khamis IS, Rollinson D, et al. (2008) A parasitological survey, in rural Zanzibar, of pre-school children and their mothers for urinary schistosomiasis, soil-transmitted helminthiases and malaria, with observations on the prevalence of anaemia. Ann Trop Med Parasitol 102: 679-692.
31. World Health Organization. (2011) Report of a meeting to review the results of studies on the treatment of schistosomiasis in preschool-age children. Geneva: World Health Organization. vi, 23 p. p.
32. Balen J, Stothard JR, Kabatereine NB, Tukahebwa EM, Kazibwe F, et al. (2006) Morbidity due to Schistosoma mansoni: an epidemiological assessment of distended abdomen syndrome in Ugandan school children with observations before and 1-year after anthelminthic chemotherapy. Trans R Soc Trop Med Hyg 100: 1039-1048.
33. Richter J, Hatz C, Haussinger D, (2003) Ultrasound in tropical and parasitic diseases. Lancet 362: 900-902.
34. Bustinduy AL, Parraga IM, Thomas CL, Mungai PL, Mutuku F, et al. (2013) Impact of Polyparasitic Infections on Anemia and Undernutrition among Kenyan Children Living in a Schistosoma haematobium-Endemic Area. Am J Trop Med Hyg 88 (3) ():: 433-40.
35. Ezeamama AE, Friedman JF, Olveda RM, Acosta LP, Kurtis JD, et al. (2005) Functional significance of low-intensity polyparasite helminth infections in anemia. J Infect Dis 192: 2160-2170.
36. Friedman JF, Kanzaria HK, McGarvey ST, (2005) Human schistosomiasis and anemia: the relationship and potential mechanisms. Trends Parasitol 21: 386-392.
37. King CH, Dickman K, Tisch DJ, (2005) Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365: 1561-1569.
38. Bustinduy AL, Thomas CL, Fiutem JJ, Parraga IM, Mungai PL, et al. (2011) Measuring fitness of Kenyan children with polyparasitic infections using the 20-meter shuttle run test as a morbidity metric. PLoS Negl Trop Dis 5: e1213.
39. Mohamed AR, al Karawi M, Yasawy MI, (1990) Schistosomal colonic disease. Gut 31: 439-442.
40. Hestvik E, Tumwine JK, Tylleskar T, Grahnquist L, Ndeezi G, et al. (2011) Faecal calprotectin concentrations in apparently healthy children aged 0-12 years in urban Kampala, Uganda: a community-based survey. BMC Pediatr 11: 9.